These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8095555)

  • 1. Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants.
    Vassout A; Bruinink A; Krauss J; Waldmeier P; Bischoff S
    J Recept Res; 1993; 13(1-4):341-54. PubMed ID: 8095555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous dopamine (DA) modulates [3H]spiperone binding in vivo in rat brain.
    Bischoff S; Krauss J; Grunenwald C; Gunst F; Heinrich M; Schaub M; Stöcklin K; Vassout A; Waldmeier P; Maître L
    J Recept Res; 1991; 11(1-4):163-75. PubMed ID: 1886078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
    Blitzer RD; Becker RE
    Psychopharmacology (Berl); 1985; 85(2):173-7. PubMed ID: 2861618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
    Bredeloux P; Dubuc I; Costentin J
    Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1997 Dec; 340(1):53-8. PubMed ID: 9527506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant mechanisms of cathinones - effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices.
    Opacka-Juffry J; Pinnell T; Patel N; Bevan M; Meintel M; Davidson C
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():122-30. PubMed ID: 24795175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment.
    Bischoff S; Bittiger H; Krauss J; Vassout A; Waldmeier P
    Eur J Pharmacol; 1984 Sep; 104(1-2):173-6. PubMed ID: 6437847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW; Johnson KM
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of CNS stimulants with phencyclidine on dopamine release using in vivo voltammetry.
    Howard-Butcher S; Blaha CD; Lane RF
    Brain Res Bull; 1984 Oct; 13(4):497-501. PubMed ID: 6151866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron.
    Shore PA
    J Pharm Pharmacol; 1976 Nov; 28(11):855-7. PubMed ID: 11304
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of bupropion on nicotine self-administration in rats.
    Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
    Miller HH; Shore PA
    Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antagonists of 5-HT
    Partyka A; Jastrzębska-Więsek M; Antkiewicz-Michaluk L; Michaluk J; Wąsik A; Canale V; Zajdel P; Kołaczkowski M; Wesołowska A
    Behav Brain Res; 2019 Feb; 359():9-16. PubMed ID: 30312638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
    Braestrup C
    J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.